Q&A With Dr. Bloxham Update 10/01/23
FT: Can you give us a quick recap of the study progress so far and what you’ve witnessed?
Dr. Bloxham: We are basically at the two month mark right now. So I have images/video from post-op day 1 through month 2. The video I am working on now and will post asap will be post-op day 1 through month 1. I then hope to put the month 2 update up quickly and basically be caught up. Then, I can shift to monthly updates.
Without giving too much away or getting into speculation, I can say two things: 1) The verteporfin is doing something. Clearly it is influencing the tissue in some manner. And with that said: 2) The treated wounds are healing differently. Now, what will this mean in the end? I don’t know. But something seems to be going on. I’ll get a little bit more into this during the 1 month update and definitely during the 2 month update.
FT: From what you’ve seen so far with the verteporfin, do you have expectations of its effectiveness in hair surgery wound healing?
Dr. Bloxham: It’s so early for this type of wound (in its total healing process), that it is hard to say. I can say, however, that the slower/different wound healing doesn’t seem to be harmful in any way. There was some concern initially that changing the wound healing process could result in a higher risk of infection, wound dehiscence, etc. However, that does not seem to be the case.
Also, effectiveness will be a little tricky to quantify now because we really don’t have a good handle on tissue concentration yet. I went up much higher compared to other studies because I believe there will be a dose dependent response (IE: the higher the concentration, the better the response — to an extent), but we still don’t know if we are going high enough to maximize the drug’s potential.